help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 65, No. 3 527-534
doi:10.1210/jcem-65-3-527
Copyright © 1987 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SMITH, S. K.
Right arrow Articles by KELLY, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SMITH, S. K.
Right arrow Articles by KELLY, R. W.

The Effect of the Antiprogestins RU 486 and ZK 98734 on the Synthesis and Metabolism of Prostaglandins F2{alpha} and E2 in Separated Cells from Early Human Decidua

S. K. SMITH and R. W. KELLY

Medical Research Council, Reproductive Biology Unit, Centre for Reproductive Biology Edinburgh, EH3 9EW Scotland

Address requests for reprints to: Dr. S. K. Smith, Medical Research Council, Reproductive Biology Unit, Centre for Reproductive Biology, 37 Chalmers Street, Edinburgh, EH3 9EW Scotland.

Enriched preparations of glandular and stromal cells were obtained from early human decidua and incubated for 24 h in the presence of two progesterone antagonists, RU 486 (17β-hydroxy-11β-[4-dimethylaminophenyl] 17{alpha}-[1-propynyl] estra-4,9-dien-3-one) and ZK 98734 (17β-hydroxy-llβ-[4-di-methylaminophenyl]17{alpha}-[3-hydroxy-l-propynyl]estra-4,9-dien-3-one) to determine the effect of the antiprogestins on the release of prostaglandin F2{alpha} (PGF2{alpha}) and PGE2 and their subsequent conversion to 15-keto-13,14-dihydro-PGF2{alpha} and 15-keto-13,14-dihydro-PGE2. In the presence of exogenous arachidonic acid (AA, 30 µM), both steroids stimulated PGF2{alpha} release by glandular, but not stromal, cells (P < 0.001) and inhibited the metabolism of PGF2{alpha} by the glandular fraction (P < 0.005 and P < 0.001 respectively). In the absence of exogenous AA, RU 486 and ZK 98734 stimulated the release of PGF2{alpha} from glandular, but not stromal, cells (P < 0.001 and P < 0.005, respectively). Neither steroid altered the release or metabolism of PGE2 when the cells were incubated with AA, but both RU 486 and ZK 98734 increased the release of PGE2 by glandular, but not stromal, cells when incubated without AA (P < 0.005 and P < 0.001, respectively). Both steroids inhibited the metabolism of PGE2 under these conditions (P < 0.05).

These results suggest that 1) antiprogestins stimulate the synthesis of PGs by glandular cells in early human decidua, but do not alter the synthesis of PGs by stromal cells; 2) this stimulation of PG synthesis involves an effect on cyclooxygenase activity and is not a consequence of increased availability of endogenous AA; 3) the metabolism of PGs by glandular cells is altered by RU 486 and ZK 98734; 4) as RU 486 has greater antiglucocorticoid activity than ZK 98734, these results suggest that both steroids act on decidua by antagonizing endogenous progesterone rather than glucocorticoid activity.

Received January 14, 1987.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. K. Hapangama, H. O. D. Critchley, T. A. Henderson, and D. T. Baird
Mifepristone-Induced Vaginal Bleeding Is Associated with Increased Immunostaining for Cyclooxygenase-2 and Decrease in Prostaglandin Dehydrogenase in Luteal Phase Endometrium
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5229 - 5234.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Weiss
Endocrinology of Parturition
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4421 - 4425.
[Full Text]


Home page
NEJMHome page
I. M. Spitz and C.W. Bardin
Mifepristone (RU 486) -- A Modulator of Progestin and Glucocorticoid Action
N. Engl. J. Med., August 5, 1993; 329(6): 404 - 412.
[Full Text]


Home page
Arch Fam MedHome page
B. D. Weiss
RU 486: The Progesterone Antagonist
Arch Fam Med, January 1, 1993; 2(1): 63 - 69.
[Abstract] [PDF]


Home page
ScienceHome page
E. Baulieu
Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor
Science, September 22, 1989; 245(4924): 1351 - 1357.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society